56 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.

University of Lille
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.

University of Lille
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

University of Lille
Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands.

University of Lille
Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands.

University of Lille
Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.

University of Lille
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.

University of Lille
Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.

University of Lille
Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.

University of Lille
New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.

University of Lille
Design, synthesis and in vitro antimalarial activity of an acylhydrazone library.

University of Lille
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.

University of Lille
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.

University of Lille
Synthesis and antimalarial evaluation of new 1,4-bis(3-aminopropyl)piperazine derivatives.

University of Lille
Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.

University of Lille
4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.

University of Lille
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.

University of Lille
Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds.

University of Lille
Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.

University of Lille
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.

University of Lille
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

University of Lille
Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.

University of Lille
Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.

University of Lille
Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).

University of Lille
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors.

University of Lille
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation.

University of Lille
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.

University of Lille
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.

University of Lille
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.

University of Lille
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.

University of Lille
Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors.

University of Lille
Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors.

University of Lille
New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold.

University of Lille
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.

University of Lille
Synthesis of a 200-member library of squaric acid N-hydroxylamide amides.

University of Lille
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.

University of Lille
Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

University of Lille
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.

University of Lille
Identification of novel quinazoline derivatives as potent antiplasmodial agents.

University of Lille
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines.

University of Lille
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

University of Lille
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.

University of Lille
Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.

University of Lille
2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.

University of Lille
Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.

University of Lille
Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

University of Lille
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.

University of Lille
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.

University of Lille
Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.

University of Lille
A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors.

University of Lille
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.

University of Lille
Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

University of Lille